ARCHIVES

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

DCE Board Approves Recompetition Concepts

March 18, 1988